To hear about similar clinical trials, please enter your email below
Trial Title:
Exercise Prehabilitation for Locoregional Esophageal Cancer
NCT ID:
NCT06430346
Condition:
Esophageal Cancer
Conditions: Official terms:
Esophageal Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Exercise
Description:
Physical activity and resistance training
Arm group label:
Exercise prehabilitation
Summary:
The purpose of the study is to examine the feasibility and acceptability of exercise
"prehabilitation" for patients preparing for esophageal cancer resection (removal).
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Biopsy-proven locoregional esophageal cancer (LEC)
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- Treatment plan including neoadjuvant chemoradiation therapy and surgical resection
- Ability to read and speak English
Exclusion Criteria:
- Regular engagement in resistance training (2x/week targeting all major muscle
groups)
- Screen failure for exercise safety based on PAR-Q
- Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
- Recent fracture or acute musculoskeletal injury that precludes ability to
participate in resistance training safely
- Numeric pain rating scale of 7 or more out of 10
- Myopathic or rheumatologic disease that impacts physical function
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Moffitt Cancer Center
Address:
City:
Tampa
Zip:
33612
Country:
United States
Status:
Recruiting
Contact:
Last name:
Nathan Parker, PhD
Phone:
813-745-0527
Email:
Nathan.Parker@moffitt.org
Investigator:
Last name:
Nathan Parker, PhD
Email:
Principal Investigator
Investigator:
Last name:
Jose Pimiento, MD
Email:
Principal Investigator
Start date:
May 21, 2024
Completion date:
May 2027
Lead sponsor:
Agency:
H. Lee Moffitt Cancer Center and Research Institute
Agency class:
Other
Source:
H. Lee Moffitt Cancer Center and Research Institute
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06430346
